Karuna Therapeutics Inc. (KRTX) PT Raised to $276 at Mizuho Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- US stock futures rise as investors assess Democrats' midterm sweep
- CVS Health plans to split into two public companies by 2028
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
Tweet
Share
E-mailGet Alerts KRTX Hot Sheet
Price: $329.83 --0%
Rating Summary:
8 Buy, 16 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 17 | New: 12
Rating Summary:
8 Buy, 16 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 17 | New: 12
Join SI Premium – FREE
Mizuho Securities analyst Vamil Divan raised the price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) to $276.00 (from $190.00) while maintaining a Buy rating.
You May Also Be Interested In
- Central Depository Services India Ltd (CDSL:IN) PT Raised to INR1,290 at JPMorgan
- Xometry Inc (XMTR) PT Raised to $140 at Wedbush
- Pfizer (PFE) PT Raised to $35 at Scotiabank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
